Oncology

The first patient to receive purified CAR-T cells is home and doing well, Charleston, S.C.-based MUSC Hollings Cancer Center said.

Of all cancer cases in men in 2024, 48% are predicted to be prostate, lung and colon and rectum and 51% of all new cases in women are expected to be from breast, lung and colon and rectum cancers, researchers…

A "legendary" Houston oncologist has developed a novel cancer treatment that boasts a complete remission rate among patients of 50%, ABC7 reported Feb. 3.

Here are six cancer vaccines showing promise or in development since May 2023: 

Early trials of a vaccine that targets a specific gene found in tumors, known as KRAS, has proven to be effective in 84% of patients who had pancreatic or colorectal cancers recur after their initial treatment, according to researchers at…

Little Rock-based University of Arkansas for Medical Sciences reached its $30 million fundraising goal and is closer to becoming a national cancer institute.

New estimates suggest that global cancer cases will spike around 77% by 2050, according to a Feb. 1 United Nations report. 

The Rutgers Cancer Institute of New Jersey has promoted two leadership positions to better situate it for support of the new Jack and Sheryl Morris Cancer Center in New Brunswick, N.J., set to open in early 2025.

Houston-based University of Texas MD Anderson Cancer Center is the first International Atomic Energy Agency Collaborating Centre in the United States focused on healthcare.

Alexandra Miller, MD, PhD, a neurologist and neuro-oncologist who specializes in brain tumors, was named chief of the neuro-oncology program and co-director of the Brain and Spine Tumor Center at New York City-based NYU Langone's Perlmutter Cancer Center.